Categories: ContentProduct
See relevant content for Intermune.com
Investors 2
Mentions in press and media 3
| Date | Title | Description |
| 11.11.2024 | New Leadership and Investment Trends: A Look at the Pulmonary Fibrosis Foundation and Thor Metals Group | In the world of healthcare and finance, leadership changes and accolades can signal shifts in strategy and focus. Recently, two organizations have made headlines: the Pulmonary Fibrosis Foundation (PFF) and Thor Metals Group. Each stands at... |
| 06.11.2024 | Pulmonary Fibrosis Foundation Announces Wayne Pan as Board Chair | Dr. Wayne Pan, Chair, Pulmonary Fibrosis Foundation Board of Directors
The Pulmonary Fibrosis Foundation, the nation's leading pulmonary fibrosis (PF) research, education and advocacy organization, has announced the election of Dr. Wayne Pa... |
| 14.05.2007 | Antibiotic maker Targanta aims for $86.3M IPO | Targanta Therapeutics, a Cambridge, Mass. drug developer at work on a new generation of antibiotics, hopes to raise $86.3 million in an initial offering, according to an SEC filing. The company didn’t specify how many shares it plans to off... |
Reviews 0
